Lancet says concerned about validity of widely-cited hydroxychloroquine study

The Lancet medical journal on Tuesday said "serious scientific questions" had been brought to its attention about the validity of the data behind a widely-cited study on the dangers of the use of the anti-malarial drug hydroxychloroquine in hospitalized patients with COVID-19.